Yasuaki Ogawa

3.0k total citations · 2 hit papers
48 papers, 2.5k citations indexed

About

Yasuaki Ogawa is a scholar working on Molecular Biology, Biomaterials and Organic Chemistry. According to data from OpenAlex, Yasuaki Ogawa has authored 48 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 12 papers in Biomaterials and 11 papers in Organic Chemistry. Recurrent topics in Yasuaki Ogawa's work include Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Lipid Membrane Structure and Behavior (5 papers). Yasuaki Ogawa is often cited by papers focused on Advanced Drug Delivery Systems (9 papers), Nanoparticle-Based Drug Delivery (7 papers) and Lipid Membrane Structure and Behavior (5 papers). Yasuaki Ogawa collaborates with scholars based in Japan, United Kingdom and United States. Yasuaki Ogawa's co-authors include Tsugio Shimamoto, Masaki Yamamoto, Takatsuka Yashiki, Hiroaki Okada, Hajime Toguchi, Yoshio Aramaki, Osamu Nishimura, Naoyuki Kanzaki, Hidekazu Sawada and Mitsuru Shiraishi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Controlled Release.

In The Last Decade

Yasuaki Ogawa

47 papers receiving 2.4k citations

Hit Papers

A small-molecule, nonpept... 1988 2026 2000 2013 1999 1988 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity
    1999 634 citations Yasuaki Ogawa et al. profile →
  2. A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid.
    1988 447 citations Yasuaki Ogawa, Hiroaki Okada et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yasuaki Ogawa Japan 24 764 758 493 419 409 48 2.5k
Riad Agbaria Israel 27 332 0.4× 774 1.0× 209 0.4× 302 0.7× 66 0.2× 51 2.3k
Tathagata Dutta India 21 563 0.7× 1.0k 1.3× 465 0.9× 140 0.3× 168 0.4× 28 1.9k
Lisa M. Kaminskas Australia 38 737 1.0× 1.6k 2.2× 926 1.9× 55 0.1× 464 1.1× 91 4.3k
Dinesh Kumar Singh United States 21 128 0.2× 1.1k 1.4× 300 0.6× 433 1.0× 416 1.0× 101 3.1k
Francisca Araújo Portugal 31 1.2k 1.6× 806 1.1× 752 1.5× 86 0.2× 126 0.3× 53 3.0k
Elke Walter Switzerland 24 769 1.0× 1.2k 1.6× 734 1.5× 29 0.1× 578 1.4× 34 2.9k
Prem N. Gupta India 37 976 1.3× 1.5k 1.9× 1.1k 2.3× 36 0.1× 478 1.2× 94 3.5k
Rachael M. Crist United States 21 112 0.1× 867 1.1× 618 1.3× 235 0.6× 201 0.5× 31 2.3k
Hervé Hillaireau France 28 652 0.9× 1.7k 2.2× 1.4k 2.8× 56 0.1× 215 0.5× 50 3.5k
Ho Lun Wong United States 27 809 1.1× 1.6k 2.0× 1.7k 3.4× 75 0.2× 125 0.3× 40 3.5k

Countries citing papers authored by Yasuaki Ogawa

Since Specialization
Citations

This map shows the geographic impact of Yasuaki Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuaki Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuaki Ogawa more than expected).

Fields of papers citing papers by Yasuaki Ogawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuaki Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuaki Ogawa. The network helps show where Yasuaki Ogawa may publish in the future.

Co-authorship network of co-authors of Yasuaki Ogawa

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuaki Ogawa. A scholar is included among the top collaborators of Yasuaki Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuaki Ogawa. Yasuaki Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mizushima, Yutaka, Toshiyuki Ikoma, Keiko Hoshi, et al.. (2005). Injectable porous hydroxyapatite microparticles as a new carrier for protein and lipophilic drugs. Journal of Controlled Release. 110(2). 260–265. 156 indexed citations
2.
Ishihara, Tsutomu, et al.. (2005). Role of zinc in formulation of PLGA/PLA nanoparticles encapsulating betamethasone phosphate and its release profile. Journal of Controlled Release. 105(1-2). 68–76. 54 indexed citations
3.
Takenaga, Mitsuko, Yoko Yamaguchi, Yasuaki Ogawa, et al.. (2003). Optimum formulation for sustained-release insulin. International Journal of Pharmaceutics. 271(1-2). 85–94. 31 indexed citations
4.
Suzuki, Yasuyuki, Katsumi Iga, Masahiro Oka, et al.. (2002). Prevention of bone loss in ovariectomized rats by pulsatile transdermal iontophoretic administration of human PTH(1–34). Journal of Pharmaceutical Sciences. 91(2). 350–361. 40 indexed citations
5.
Takenaga, Mitsuko, et al.. (2002). A novel insulin formulation can keep providing steady levels of insulin for much longer periods in-vivo. Journal of Pharmacy and Pharmacology. 54(9). 1189–1194. 12 indexed citations
6.
7.
Ogawa, Yasuaki. (2000). Microcapsules prepared with biodegradable polymer for prolonged release of drugs.. Drug Delivery System. 15(5). 429–436. 3 indexed citations
8.
Inuzuka, Hiroyuki, et al.. (1995). A Sensitive ELISA for the Characterization of Two Forms of Circulating Intercellular Adhesion Molecule-1 in Human Plasma.. Biological and Pharmaceutical Bulletin. 18(8). 1036–1040. 5 indexed citations
9.
Heya, Toshiro, Hiroaki Okada, & Yasuaki Ogawa. (1995). Controlled release microspheres of thyrotropin releasing hormone using copoly (lactic/glycolic acid).. MEMBRANE. 20(4). 270–275.
10.
11.
12.
Okada, Hiroaki, et al.. (1994). Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers. Pharmaceutical Research. 11(8). 1143–1147. 172 indexed citations
13.
Igari, Yasutaka, et al.. (1993). Sustained release preparation of erythropoietin using sodium hyaluronate.. Drug Delivery System. 8(4). 237–241. 2 indexed citations
14.
15.
Okada, Hiroaki, et al.. (1992). Anticancer effects of chemoembolization using microspheres of an angiogenesis inhibitor (TNP-470) in rabbits bearing VX-2 carcinoma.. Drug Delivery System. 7(2). 97–102. 3 indexed citations
16.
Iga, Katsumi, et al.. (1991). Increased Tumor Cisplatin Levels in Heated Tumors in Mice after Administration of Thermosensitive, Large Unilamellar Vesicles Encapsulating Cisplatin. Journal of Pharmaceutical Sciences. 80(6). 522–525. 23 indexed citations
17.
Toguchi, Hajime, Yasuaki Ogawa, Hiroaki Okada, & Masaki Yamamoto. (1991). Once-a-Month Injectable Microcapsules of Leuprorelin Acetate. YAKUGAKU ZASSHI. 111(8). 397–409. 10 indexed citations
18.
Ogawa, Yasuaki. (1990). Controlled release microcapsule dosage form using biodegradable polymers containing a water-soluble peptide.. Journal of the Society of Powder Technology Japan. 27(8). 534–540. 1 indexed citations
19.
Inouye, Shigeharu, Michio Kojima, TAKASHI SHOMURA, et al.. (1983). Discovery,isolation and structure of novel cephamycins of Streptomyces chartreusis.. The Journal of Antibiotics. 36(2). 115–124. 8 indexed citations
20.
Itoh, Jiro, SHOICHI AMANO, Yasuaki Ogawa, et al.. (1980). Studies on antibiotics BN-227 and BN-227-F, new antibiotics. II. Chemical structure of antibiotics BN-227 and BN-227-F.. The Journal of Antibiotics. 33(4). 377–382. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Riad Agbaria Breakdown of academic impact, for papers by Tathagata Dutta Breakdown of academic impact, for papers by Lisa M. Kaminskas Breakdown of academic impact, for papers by Dinesh Kumar Singh Breakdown of academic impact, for papers by Francisca Araújo Breakdown of academic impact, for papers by Elke Walter Breakdown of academic impact, for papers by Prem N. Gupta Breakdown of academic impact, for papers by Rachael M. Crist Breakdown of academic impact, for papers by Hervé Hillaireau Breakdown of academic impact, for papers by Ho Lun Wong
Rankless by CCL
2026